Akers planning U.S. listing, offering

Diagnostic company Akers Biosciences Inc. (LSE:AKR) proposed to list on NASDAQ and raise up to $15 million in a follow-on underwritten by Aegis Capital. Akers develops and markets point-of-care testin...